AMD Beyond Complement and Serine Protease Pathways
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2007 - March 31, 2010
Grant ID
M2007084
Goals
This study will characterize two new genetic risk factors related to wet and dry AMD
Summary
Age-related macular degeneration (AMD) has a complex etiology and is broadly classified as either dry or wet. The dry form is more common, accounting for approximately 90% of patients, and does not typically result in blindness. About 10% of patients have the wet form, in which central vision will be destroyed. We have identified two major genetic factors predisposing some individuals to the more aggressive wet form of AMD and others to the slowly progressing dry type. Together with the new risk factors we will discover, it will be possible to detect who is at increased risk and allow those affected to take preventive measures.
Grants
Related Grants
Macular Degeneration Research
Anti-Drusen Nanobodies for AMD
Active Dates
April 01, 2010 - October 01, 2012
Principal Investigator
Anne Messer, PhD
Anti-Drusen Nanobodies for AMD
Active Dates
April 01, 2010 - October 01, 2012
Principal Investigator
Anne Messer, PhD
Macular Degeneration Research
OA1 Signaling and AMD
Active Dates
April 01, 2010 - May 31, 2012
Principal Investigator
Brian Mckay, PhD
OA1 Signaling and AMD
Active Dates
April 01, 2010 - May 31, 2012
Principal Investigator
Brian Mckay, PhD
Macular Degeneration Research
CCR3 Biology and Imaging Applied to CNV in AMD
Active Dates
April 01, 2010 - June 25, 2012
Principal Investigator
Judit Baffi, MD, PhD
CCR3 Biology and Imaging Applied to CNV in AMD
Active Dates
April 01, 2010 - June 25, 2012
Principal Investigator
Judit Baffi, MD, PhD